Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer. | Gut Microbes | 2022 | 36369736 | PubTator, text mining | PubMed |
| Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection. | BMC Infect Dis | 2022 | 36368952 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions. | Viruses | 2022 | 36366532 | PubTator, text mining | PubMed |
| Oral Microbiota and Tumor-A New Perspective of Tumor Pathogenesis. | Microorganisms | 2022 | 36363799 | PubTator, text mining | PubMed |
| Helicobacter pylori in the Oral Cavity: Current Evidence and Potential Survival Strategies. | Int J Mol Sci | 2022 | 36362445 | PubTator, text mining | PubMed |
| Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. | Int J Mol Sci | 2022 | 36362402 | PubTator, text mining | PubMed |
| Old and New Blood Markers in Human Colorectal Cancer. | Int J Mol Sci | 2022 | 36361758 | PubTator, text mining | PubMed |
| The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer. | Biomedicines | 2022 | 36359346 | PubTator, text mining | PubMed |
| Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. | ACS Nano | 2022 | 36354238 | PubTator, text mining | PubMed |
| Effects of CEACAM1 in oral keratinocytes on HO-1 expression induced by Candida β-glucan particles. | J Appl Oral Sci | 2022 | 36350873 | PubTator, text mining | PubMed |
| CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis. | Front Immunol | 2022 | 36341379 | PubTator, text mining | PubMed |
| Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells. | Front Immunol | 2022 | 36341352 | PubTator, text mining | PubMed |
| hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target. | Front Pharmacol | 2022 | 36339596 | PubTator, text mining | PubMed |
| The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. | Front Oncol | 2022 | 36338731 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Cancer cell intrinsic TIM-3 induces glioblastoma progression. | iScience | 2022 | 36325060 | PubTator, text mining | PubMed |
| Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin. | Nat Commun | 2022 | 36323693 | PubTator, text mining | PubMed |
| Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy. | Mol Ther Methods Clin Dev | 2022 | 36320412 | PubTator, text mining | PubMed |
| Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. | J Immunother Cancer | 2022 | 36319064 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=31